Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials
Morra M, Elgebaly A, Elmaraezy A, Khalil A, Altibi A, Vu T, Mostafa M, Huy N, Hirayama K. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials. The Journal Of Headache And Pain 2016, 17: 63. PMID: 27377706, PMCID: PMC4932020, DOI: 10.1186/s10194-016-0651-8.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsTrigeminal neuralgiaBTX-AMeta-analysisSafety of BTX-AEfficacy of botulinum toxin type AMeta-analysis of randomized controlled trialsControlled trialsSystematic reviewRecurrent pain attacksTreatment of TNPublished randomized controlled trialsNo significant heterogeneityBTX-A groupBotulinum toxin type ABotulinum toxin A therapyPain attacksTN patientsToxin type AA therapyClinical outcomesTreatment optionsTherapeutic efficacyQuality of lifeProportion of respondents